Endogenous antigen presentation by MHC class II molecules
- PMID: 7616053
- DOI: 10.1007/BF02935617
Endogenous antigen presentation by MHC class II molecules
Abstract
T cell recognition of antigen requires that a complex form between peptides derived from the protein antigen and cell surface glycoproteins encoded by genes within the major histocompatibility complex (MHC). MHC class II molecules present both extracellular (exogenous) and internally synthesized (endogenous) antigens to the CD4 T cells subset of lymphocytes. The mechanisms of endogenous antigen presentation are the subject of this review. Isolation and amino acid sequencing of peptides bound to the class II molecule indicate that a very high proportion (70-90%) of the total peptides presented by the class II molecule are in fact derived from the pool of proteins that are synthetized within the antigen-presenting cell (APC). This type of sequence information as well as the study of model antigens has indicated that proteins expressed in a diversity of intracellular sites, including the cell surface, endoplasmic reticulum and cytosol can gain access to the class II molecule, albeit with different efficiencies. The main questions that remain to be answered are the intracellular trafficking patterns that allow colocalization of internally synthesized antigens with the class II molecule, the site(s) within the cell where peptide:class II molecule complex formation can take place and whether presentation of 'foreign' as well as 'self' antigens takes place by mechanisms that vary from one cell type to another or that vary with the metabolic state of the APC. If such variability exists, is would imply that the array of peptides displayed by class II molecules at the cell surface has similar variability, a possibility that would impact on self tolerance and autoimmunity.
Similar articles
-
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.J Virol. 2002 Nov;76(21):10929-41. doi: 10.1128/jvi.76.21.10929-10941.2002. J Virol. 2002. PMID: 12368336 Free PMC article.
-
Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.J Exp Med. 1995 Nov 1;182(5):1481-91. doi: 10.1084/jem.182.5.1481. J Exp Med. 1995. PMID: 7595218 Free PMC article.
-
LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.Immunology. 2010 Nov;131(3):318-30. doi: 10.1111/j.1365-2567.2010.03309.x. Immunology. 2010. PMID: 20518820 Free PMC article.
-
Endogenous pathway of class II presentation.Biochem Soc Trans. 1995 Aug;23(3):657-60. doi: 10.1042/bst0230657. Biochem Soc Trans. 1995. PMID: 8566437 Review.
-
The ins and outs of MHC class II-mediated antigen processing and presentation.Nat Rev Immunol. 2015 Apr;15(4):203-16. doi: 10.1038/nri3818. Epub 2015 Feb 27. Nat Rev Immunol. 2015. PMID: 25720354 Free PMC article. Review.
Cited by
-
The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.J Immunol. 2012 May 1;188(9):4235-48. doi: 10.4049/jimmunol.1103640. Epub 2012 Mar 30. J Immunol. 2012. PMID: 22467652 Free PMC article.
-
Understanding the focused CD4 T cell response to antigen and pathogenic organisms.Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7. Immunol Res. 2009. PMID: 19198764 Review.
-
The role of major histocompatibility complex molecules in luteal function.Reprod Biol Endocrinol. 2003 Nov 10;1:93. doi: 10.1186/1477-7827-1-93. Reprod Biol Endocrinol. 2003. PMID: 14613531 Free PMC article. Review. No abstract available.
-
Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.Mucosal Immunol. 2011 Jul;4(4):428-37. doi: 10.1038/mi.2010.90. Epub 2011 Jan 26. Mucosal Immunol. 2011. PMID: 21270773 Free PMC article.
-
A modified human ELISPOT assay to detect specific responses to primary tumor cell targets.J Transl Med. 2004 Mar 29;2(1):9. doi: 10.1186/1479-5876-2-9. J Transl Med. 2004. PMID: 15050026 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials